Evidence map›Paper›PMID 30062795›Full record

ArticleThe Journal of pathology2018

Pulmonary metastatic colonisation and granulomas in NOX2-deficient mice.

Louise van der Weyden, Anneliese O Speak, Agnieszka Swiatkowska, Simon Clare, Andrea Schejtman, Giorgia Santilli, Mark J Arends, David J Adams

Open access · hybridAbstract read
In one paragraph

Article in The Journal of pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.6field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Granuloma Formation in aInternational journal of molecular sciences · 2021
    Article
  14. Article
  15. Review
  16. Article
  17. From Flies to Men: ROS and the NADPH Oxidase in Phagocytes.Frontiers in cell and developmental biology · 2021
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Louise van der WeydenWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
Anneliese O SpeakWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
Agnieszka SwiatkowskaWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
Simon ClareWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
Andrea SchejtmanMolecular and Cellular Immunology (III), UCL Great Ormond Street Institute of Child Health, London, UK.
Giorgia SantilliMolecular and Cellular Immunology (III), UCL Great Ormond Street Institute of Child Health, London, UK.
Mark J ArendsUniversity of Edinburgh, Division of Pathology, Centre for Comparative Pathology, Cancer Research UK Edinburgh Centre, Institute of Genetics & Molecular Medicine, Western General Hospital, Edinburgh, UK.ORCID 0000-0002-6826-8770
David J AdamsWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.ORCID 0000-0001-9490-0306
Wellcome Sanger Institute · GBGreat Ormond Street Hospital · GBWestern General Hospital · GB

Funding

Cancer Research UK C20510/A13031European Research Council 319661Wellcome TrustWellcome Trust WT098051
6 · The paper itself

Abstract

Metastasis is the leading cause of death in cancer patients, and successful colonisation of a secondary organ by circulating tumour cells (CTCs) is the rate-limiting step of this process. We used tail-vein injection of B16-F10 melanoma cells into mice to mimic the presence of CTCs and to allow for the assessment of host (microenvironmental) factors that regulate pulmonary metastatic colonisation. We found that mice deficient for the individual subunits of the NADPH oxidase of myeloid cells, NOX2 (encoded by Cyba, Cybb, Ncf1, Ncf2, and Ncf4), all showed decreased pulmonary metastatic colonisation. To understand the role of NOX2 in controlling tumour cell survival in the pulmonary microenvironment, we focused on Cyba-deficient (Cyba

Indexed as

Cell MovementAnimalsCell Line, TumorCytochrome b GroupGranulomaKiller Cells, NaturalLung NeoplasmsLymphocyte ActivationLymphocytes, Tumor-InfiltratingMelanoma, ExperimentalMice, KnockoutNADPH Oxidase 2NADPH OxidasesNeoplasm InvasivenessNeoplastic Cells, CirculatingT-LymphocytesCyba protein, mouseCybb protein, mouseCytochrome b GroupNADPH Oxidase 2NADPH OxidasescolonisationgranulomametastasisNOX2p22phoxreactive oxygen species

Identifiers

PMID30062795
PMCPMC6221033
OpenAlexW2887421370

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.